Vol 5, Supplement 1 (June 27, 2016): Translational Cancer Research

Editorial

The genetic heterogeneity of hepatocellular carcinoma and the implications for personalised medicine

Marco Y. W. Zaki, Helen L. Reeves

PDF Pages: S1-S4 Full Text (6466) COI Form Open Access

Allogeneic anti-CD19 CAR T cells: new perspectives in the treatment of B-cell malignancies that progress after allogeneic stem cell transplantation?

Maël Heiblig, Gilles Salles, Xavier Thomas

PDF Pages: S5-S8 Full Text (6581) COI Form Open Access

Gene therapy-based prophylaxis to rescue the “prima ballerina”

Francesco Bernardi, Mirko Pinotti

PDF Pages: S9-S12 Full Text (3355) COI Form Open Access

The role of nuclear factor-kappa B and endoplasmic reticulum stress in hepatitis B viral-induced hepatocellular carcinoma

Joe Yeong, Valerie Chew

PDF Pages: S13-S17 Full Text (4667) COI Form Open Access

Dual targeting of EGFR: ready for prime time?

Hui K. Gan, Antony W. Burgess, Adam C. Parslow, Andrew M. Scott

PDF Pages: S18-S21 Full Text (4426) Open Access

Expanding treatment options for metastatic gastric cancer

Giandomenico Roviello, Giulia Borsella, Daniele Generali

PDF Pages: S22-S24 Full Text (4183) COI Form Open Access

Moving molecular subtypes to the clinic in gastric cancer

Joseph Chao, Jeeyun Lee, Samuel J. Klempner

PDF Pages: S25-S30 Full Text (6491) Open Access

Clinical translation of predictive markers for anti-EGFR monoclonal antibody therapy in metastatic colorectal cancer

Andrew Rowland, Christos S. Karapetis, Arduino A. Mangoni, Michael D. Wiese, Ganessan Kichenadasse, Ross A. McKinnon, Michael J. Sorich

PDF Pages: S31-S34 Full Text (3947) COI Form Open Access

Taking action on actionable mutations: a French initiative on universality in precision cancer care

Michael Cabanero, Ming-Sound Tsao

PDF Pages: S35-S39 Full Text (4330) COI Form Open Access

Intraoperative subtyping of lung adenocarcinoma: an unmet need

Nurlan Aliyev, Yusuke Takahashi, Shaohua Lu, Marissa Mayor, Prasad S. Adusumilli

PDF Pages: S40-S43 Full Text (5551) COI Form Open Access

Is there really a role for the comprehensive geriatric assessment in metastatic non-small cell lung cancer?

Charlotte Leduc, Elisabeth Quoix

PDF Pages: S44-S46 Full Text (3679) COI Form Open Access

Screening for mutations in lung cancer in France: purpose of precision medicine

Anne-Marie Ruppert, Jacques Cadranel, Marie Wislez

PDF Pages: S47-S49 Full Text (3998) COI Form Open Access

Clinical significance of miR-15 and miR-16 in ovarian cancer

Heidi Schwarzenbach

PDF Pages: S50-S53 Full Text (4290) COI Form Open Access

Microtubule targeting agents in glioma

Anda-Alexandra Calinescu, Maria G. Castro

PDF Pages: S54-S60 Full Text (10433) COI Form Open Access

Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity?

David Marc Davies, John Maher

PDF Pages: S61-S65 Full Text (11723) COI Form Open Access

Innate immunosurveillance: the next frontier in the cancer immunotherapy toolbox

Amy E. Gillgrass, Ali A. Ashkar

PDF Pages: S66-S70 Full Text (4223) COI Form Open Access

Perspective

Surrounding break up after Helicobacter pylori eradication to prevent metachronous gastric cancer after endoscopic submucosal resection

Nam Gil Cho, Hak Soo Kim, Ga Won Song, Jong-Min Park, Weon Jin Ko, Ki Baik Hahm

PDF Pages: S71-S75 Full Text (4296) COI Form Open Access

Precision oncology: identifying predictive biomarkers for the treatment of metastatic renal cell carcinoma

Parth K. Modi, Nicholas J. Farber, Eric A. Singer

PDF Pages: S76-S80 Full Text (7222) COI Form Open Access

Commentary

Identification of molecular subtypes and significantly mutated genes in gastric cancer using next-generation sequencing

Byungho Lim, Seon-Young Kim

PDF Pages: S81-S83 Full Text (4100) COI Form Open Access

Biomarkers and stage II colorectal cancer therapy

Ritika Zijoo, Anthony J. Olszanski, David S. Weinberg

PDF Pages: S84-S86 Full Text (3290) Open Access

The role of Sym004, a novel EGFR antibody mixture, in patients with refractory colorectal cancer

Elena Fountzilas, George Pentheroudakis

PDF Pages: S87-S90 Full Text (3245) COI Form Open Access

Unearthing a novel tumor suppressor function of ATOH8 in hepatocellular carcinoma: role in acquisition of cancer stem cell-like features

Fung Zhao, Jun Yu

PDF Pages: S91-S94 Full Text (4064) COI Form Open Access

Impact of genomic heterogeneity associated with acquired anti-EGFR resistance in colorectal cancers

Guoli Chen, Ming-Tseh Lin

PDF Pages: S95-S98 Full Text (5561) COI Form Open Access

Can we effective use sym004 in tumours harboring EGFR extracellular domain mutations?

Mahmut Uçar, Veli Berk

PDF Pages: S99-S100 Full Text (2800) COI Form Open Access

MET exon 14 mutation: another actionable genomic variation in patients with advanced NSCLC

Massimo Di Maio, Paolo Bironzo, Giorgio Vittorio Scagliotti

PDF Pages: S101-S105 Full Text (4092) COI Form Open Access

Repurposing an HIV drug to improve efficacy of targeted therapy in melanoma

Lawrence W. Wu, Gao Zhang, Meenhard Herlyn

PDF Pages: S106-S108 Full Text (3824) COI Form Open Access

Commentary on the GEC-ESTRO trial: is partial breast irradiation ready for prime time?

Kazuhiko Sato

PDF Pages: S109-S112 Full Text (3256) COI Form Open Access

Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ—is the pain worth the gain?—a commentary on the NSABP-B35 trial

Kirsty E. Stuart, John Boyages

PDF Pages: S113-S116 Full Text (3746) Open Access

Concurrent or sequential letrozole with adjuvant breast radiotherapy

Icro Meattini, Giulio Francolini, Lorenzo Livi

PDF Pages: S117-S119 Full Text (2730) COI Form Open Access

Concurrent or sequential letrozole with adjuvant breast radiotherapy

Orit Kaidar-Person, Timothy M. Zagar

PDF Pages: S120-S122 Full Text (4673) COI Form Open Access

Fat lure: adipocytes attract cancer cells out of the prostate

Alexandra M. Blee, Haojie Huang

PDF Pages: S123-S125 Full Text (6041) COI Form Open Access

Surgical intervention and circulating tumor cell count: a commentary

Jocelyn R. Marshall, Michael R. King

PDF Pages: S126-S128 Full Text (5243) COI Form Open Access

Fat talks: a new role for adipose tissue in promoting prostate cancer in obesity

Matthew J. Watt, Renea A. Taylor

PDF Pages: S129-S132 Full Text (4799) COI Form Open Access

miR-15a and miR-16 supplementation as a potential remedy for ovarian cancer

P. Anoop Chandran, Sebastian Häusler, Jörg Wischhusen

PDF Pages: S133-S135 Full Text (3776) COI Form Open Access

Emerging roles in prolactin-mediated BRCA1 function

Da Li, Qi-Jun Wu

PDF Pages: S136-S138 Full Text (3555) COI Form Open Access

Epigenetics of cancer: the role of histone methyltransferase, SETDB1, in cancer metastasis

Jeng-Wei Lu, C. K. James Shen, Tsai-Yu Tzeng

PDF Pages: S139-S141 Full Text (5572) COI Form Open Access

A novel role for Cish in the inhibition of TCR signaling

Tara S. Abraham, Adam E. Snook

PDF Pages: S142-S145 Full Text (5393) COI Form Open Access

Role of c-MYC/miRNA-548/HDAC6 axis in drug resistance and lymphoma survival

Waseem Gul Lone, Jiayu Yu, Javeed Iqbal

PDF Pages: S146-S148 Full Text (3267) COI Form Open Access

Correspondence

Radiation, cytokines and T-cell checkpoints: can we cure metastatic cancer?

Brendan D. Curti

PDF Pages: S149-S150 Full Text (2976) Open Access

News

2015 impact factor of Translational Cancer Research: 1.757

Editorial Office

PDF Pages: S151 Full Text (2308) Open Access

Disclosure:

This supplement was published without any sponsorship or funding.